Allogeneic Bone Marrow Transplantation for Chemotherapy-Refractory Hepatosplenic γδ T-Cell Lymphoma
Authors:
- Jennifer Ann DommJDJennifer Ann Domm
- MaryAnn ThompsonMTMaryAnn Thompson
- John Frank KutteschJKJohn Frank Kuttesch
- Sari AcraSASari Acra
- Haydar FrangoulHFHaydar Frangoul
- 1 November 2005
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 27 (11) , 607-610
Abstract
Hepatosplenic gammadelta T-cell lymphoma is an uncommon pediatric disease and is associated with an aggressive and often fatal course. The authors describe the case of an 8-year-old girl who presented with transaminitis and hepatosplenomegaly. Liver biopsy and peripheral blood flow cytometry were diagnostic of hepatosplenic gammadelta T-cell lymphoma. She was treated with multi-agent chemotherapy with cyclophosphamide, vincristine, prednisone, doxorubicin, and high-dose methotrexate but failed to achieve durable remission. She underwent an allogeneic bone marrow transplant from her HLA-identical brother with a preparative regimen including total body irradiation and cyclophosphamide. She is currently alive and has remained in remission for 30 months after transplantation. The authors also review the literature for similar pediatric cases.Keywords
This publication has 7 references indexed in Scilit:
- Hemophagocytic Syndrome and Hepatosplenic ???? T-Cell Lymphoma With Isochromosome 7q and 8 TrisomyJournal of Pediatric Hematology/Oncology, 2004
- Hepatosplenic ?? T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantationAmerican Journal of Hematology, 2004
- Hepatosplenic T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patientsBlood, 2003
- Hepatosplenic γ/δ T-Cell Lymphoma With Isochromosome 7q, Translocation t(7;21), and Tetrasomy 8 in a 9-Year-Old GirlJournal of Pediatric Hematology/Oncology, 2002
- Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990Leukemia, 2000
- Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell originBlood, 1996
- Hepatosplenic gamma‐delta T‐cell malignant lymphoma: report of the first case in childhood, including molecular minimal residual disease follow‐upBritish Journal of Haematology, 1995